COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,389 Articles (22,816 medRxiv, 8,573 bioRxiv)

Most recent first Previous |  Page 719: Articles 7181-7190  | Next

Nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on viral spike glycoprotein
Piacentini, S., Riccio, A., Santopolo, S., Pauciullo, S., Rossi, A., Rossignol, J.-F., Santoro, M. G.
10.1101/2022.07.13.499346 — Posted: 2022-07-13
Structural basis for the enhanced infectivity and immune evasion of Omicron subvariants
Li, Y., Shen, Y., Zhang, Y., Yan, R.
10.1101/2022.07.13.499586 — Posted: 2022-07-13
Pathobiology and dysbiosis of the respiratory and intestinal microbiota in 14 months old Golden Syrian hamsters infected with SARS-CoV-2
Seibert, B., Caceres, C. J., Carnaccini, S., Cardenas-Garcia, S., Gay, L. C., Ortiz, L., Geiger, G., de Souza Rajao, D. S., Ottesen, E., Perez, D. R.
10.1101/2022.07.13.499851 — Posted: 2022-07-13
Inducible Bronchus-Associated Lymphoid Tissue in SARS-CoV-2 Infected Rhesus Macaques
Ma, Z.-M., Olstad, K. J., Van Rompay, K. K. A., Iyer, S. S., Miller, C. J., Reader, J. R.
10.1101/2022.07.12.499813 — Posted: 2022-07-13
Efficient Tracing of the SARS-CoV-2 Omicron Variants in Santa Barbara County Using a Rapid Quantitative Reverse Transcription PCR Assay
Aralis, Z., Comer, S., Ansorg, H., Palmer, C., Smith, J., Feinstein, S., Fitzgibbons, L. N., Arias, C.
10.1101/2022.07.12.22277554 — Posted: 2022-07-13
Urban pandemic response: survey results describing the experiences from twenty-five cities during the COVID-19 pandemic.
Boyce, M. R., Cordoba Asprilla, M., van Loenen, B., McClelland, A., Rojhani, A.
10.1101/2022.07.12.22277559 — Posted: 2022-07-13
Inhaled Fluticasone for Outpatient Treatment of Covid-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial
Naggie, S.
10.1101/2022.07.12.22277548 — Posted: 2022-07-13
Comparative analysis of retracted pre-print and peer-reviewed articles on COVID-19
Sra, M. S., Arora, M., Mazumder, A., Goyal, R. M., Parameswaran, G. G., Meena, J. K.
10.1101/2022.07.12.22277529 — Posted: 2022-07-12
Insights from Incorporating Quantum Computing into Drug Design Workflows
Lau, B., Emani, P. S., Chapman, J., Yao, L., Lam, T., Merrill, P., Warrell, J., Gerstein, M. B., Lam, H.
10.1101/2022.07.11.499644 — Posted: 2022-07-12
Enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants BA.4 and BA.5
Reuschl, A.-K., Thorne, L. G., Whelan, M. X. V., Mesner, D., Ragazzini, R., Dowgier, G., Bogoda, N., Turner, J. E., Furnon, W., Cowton, V. M., de Lorenzo, G., Bonfanti, P., Palmarini, M., Patel, A. H., Jolly, C., Towers, G. J.
10.1101/2022.07.12.499603 — Posted: 2022-07-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).